Thromboprophylaxis and the relationship between C-reactive protein and plasma fibrinogen in patients with acute exacerbations of COPD

M. Jones, E. Evans (Swansea, United Kingdom)

Source: Annual Congress 2007 - Exacerbations of COPD
Session: Exacerbations of COPD
Session type: Thematic Poster Session
Number: 3313
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Jones, E. Evans (Swansea, United Kingdom). Thromboprophylaxis and the relationship between C-reactive protein and plasma fibrinogen in patients with acute exacerbations of COPD. Eur Respir J 2007; 30: Suppl. 51, 3313

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The importance of C-reactive protein in patients with acute exacerbation of severe COPD
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019

C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD
Source: Eur Respir J 2015; 45: 76-86
Year: 2015



Procalcitonin versus C-reactive protein in the management of severe acute exacerbations of COPD
Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD
Year: 2010


Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1515-1516
Year: 2015


Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1514-1515
Year: 2015


COPD, asthma and C-reactive protein
Source: Eur Respir J 2006; 27: 874-876
Year: 2006


Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008


Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009


C-reactive protein levels and clinically important predictive outcomes in stable COPD patients
Source: Eur Respir J 2006; 27: 902-907
Year: 2006



Analysis of IgE and C-reactive protein as possible predictors of exacerbation patients with asthma
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011

Procalcitonin and C-reactive protein levels in infective attacks of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 337s
Year: 2003

Serum C-reactive protein 14 days after a COPD exacerbation and time to the next exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 177s
Year: 2006

Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Increased plasma fibrinogen could predict frequent exacerbations in asthma
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients.
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


Effect of acute exacerbations on circulating thrombotic and fibrinolytic markers in COPD patients
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011


PP302 – The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension
Source: ERS Lung Science Conference 2021
Year: 2021

C-reactive protein usefulness in diagnosis and follow-up of COPD infectious exacerbations
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007


Is there a relationship between severity of COPD and C-reactive protein (CRP) levels?
Source: Eur Respir J 2006; 28: Suppl. 50, 37s
Year: 2006

C-reactive protein (CRP) as a risk marker in COPD patients with ischaemic heart disease
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008